c-LEcta announced the launch of DENARASE® High Salt, an engineered version of its product DENARASE. DENARASE is a recombinantly produced Serratia marcescens endonuclease that is used for removal of DNA/RNA impurities during the production of biopharmaceuticals. The newest addition to the DENARASE portfolio has been designed to retain activity at higher salt concentrations and a broad pH spectrum. DENARASE High Salt was developed using c-LEcta’s proprietary enzyme technology platform ENESYZ®.
